Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial

Clinical trial NCT04662684 · COMPLETED

Trial details

NCT number: NCT04662684
Sponsor: Science Valley Research Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 Venous Thromboembolism

Start date: 2020-10-16
Primary completion: 2021-07-10
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.